Go to the list of all blogs
John Y White's Avatar
published in Blogs
Oct 02, 2026
TSLL Performance Snapshot: +5% Over 30 Days but -20% Over Three Months

TSLL Performance Snapshot: +5% Over 30 Days but -20% Over Three Months

Key Takeaways

  • TSLL is a leveraged, single-stock exchange-traded fund (ETF) seeking daily investment results, before fees and expenses, equal to 200% of the daily performance of TSLA (Tesla) common stock.
  • The fund is concentrated in one underlying equity exposure and rebalances daily, creating compounding and volatility effects over holding periods longer than a single day.
  • TSLL has gained roughly 5% over the trailing 30 days but remains about 20% below its level from three months earlier, reflecting a sharp late-July drawdown.
  • Because performance depends almost entirely on one company, the fund offers minimal diversification or broad sector balance.
  • Principal risks include single-stock concentration, 2x leverage, and daily compounding that can amplify losses in volatile markets.

Understanding the Direxion Daily TSLA Bull 2X Shares (TSLL)

The Direxion Daily TSLA Bull 2X Shares is a leveraged, single-stock ETF that seeks daily investment results, before fees and expenses, equal to 200% of the daily performance of TSLA common stock. Launched in August 2022, the fund holds roughly $3.6 billion in assets under management (AUM) and carries a net expense ratio of approximately 0.83%, with a gross expense ratio of about 0.96%.

Unlike a diversified fund, TSLL does not hold a broad basket of companies. Its portfolio is built around a single underlying equity exposure—Tesla—implemented primarily through swap agreements, with cash and U.S. Treasury securities held as collateral. This structure means the fund's total return depends almost entirely on the daily price action of one stock, rather than on sector leadership or broad index performance. I also checked this using Tickeron’s AI Screener to see how the fund compares to others in the industry.

The fund targets two times (2x) the daily move of Tesla and resets its exposure each trading day. Because the target is reset daily, returns over periods longer than one day will generally differ from twice the cumulative return of Tesla, particularly when markets are volatile. This daily-compounding dynamic is a defining feature of the fund's performance profile.

Industry and Thematic Landscape

TSLL's investment theme is inseparable from the electric-vehicle (EV) industry and Tesla's broader business, which spans automotive manufacturing, energy generation and storage, and services. Investor sentiment toward these segments is shaped by vehicle delivery volumes, pricing and margin trends, battery technology, and growing competition from legacy automakers and Chinese EV producers.

The macroeconomic environment also matters. Interest rates influence auto-financing costs and the valuation of high-growth, capital-intensive companies, while inflation and consumer demand affect purchasing decisions. Regulatory and trade policy, including tariffs and rules governing autonomous-driving technology, can shift the outlook for both Tesla and the wider sector. Tesla's longer-term initiatives—such as Full Self-Driving software, robotaxi ambitions, and robotics—add a technology-driven dimension that can move sentiment independently of near-term vehicle sales.

Performance and Positioning Snapshot

Over the trailing 30 days, TSLL has risen roughly 5%, but the path has been uneven. The fund has alternated between multi-day gains and pullbacks as Tesla shares fluctuated, underscoring how quickly 2x leverage can magnify short-term moves. Over the trailing three months, however, TSLL is down approximately 20%. Much of that decline occurred in late July, when Tesla sold off sharply and the fund's leverage amplified the move; a single-session drop of roughly 29% in TSLL illustrates the concentrated risk embedded in the structure.

Recent performance has been driven by identifiable factors rather than gradual trend. Tesla's share-price swings—responding to delivery and earnings expectations, competition in the EV market, and shifts in sentiment toward autonomous-driving and artificial-intelligence themes—have translated directly into amplified moves in TSLL. Because the fund holds effectively one exposure, there is no offsetting diversification from other sectors, so its positioning snapshot closely mirrors Tesla's own volatility multiplied by two. From what I see, this makes monitoring TSLA movements especially important for anyone holding the leveraged product.

2026 Outlook and Key Factors to Monitor

Looking ahead, the most important variables for TSLL are the same forces that drive Tesla. Vehicle delivery growth, new model launches, and margin trends will shape the near-term earnings cycle, while progress in energy storage, Full Self-Driving, robotaxi deployment, and robotics could influence longer-term valuation. Competition, particularly on price, remains a key structural risk for the EV industry.

On the macro front, interest-rate expectations and inflation trends will affect both financing demand and how investors value growth-oriented equities. Trade policy and regulatory decisions around autonomous driving could create either tailwinds or headwinds. Finally, investors should monitor capital flows into leveraged single-stock products and remain aware that daily rebalancing and 2x leverage make TSLL a high-volatility instrument better suited to short-term trading than to long-term buy-and-hold positioning. I'm watching this closely as volatility in the underlying stock continues to shape outcomes.

Using Tickeron’s AI Tools in My Research

I regularly turn to Tickeron’s AI Screener when evaluating leveraged products like this one. The platform helps scan for technical signals, volatility patterns, and comparable ideas across thousands of securities, which can surface opportunities or risks that a single-ticker focus might miss. It has become a practical part of my workflow for putting context around concentrated bets such as TSLL.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: TSLL

Contributor

John Y White's AvatarJohn Y White|Beginner

Experienced trader focused on market analysis, identifying trading opportunities, and developing custom trading signals based on market trends, price action, and data-driven insights. Join my Trader Club to follow my latest analysis, trading ideas, and active signals: https://tickeron.com/app/trader-club/103/view?tab=active&section=trades&via=john


TSLL sees its Stochastic Oscillator ascends from oversold territory

On October 02, 2026, the Stochastic Oscillator for TSLL moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 46 instances where the indicator left the oversold zone. In 42 of the 46 cases the stock moved higher in the following days. This puts the odds of a move higher at over 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 02, 2026. You may want to consider a long position or call options on TSLL as a result. In 60 of 66 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 90%.

TSLL moved above its 50-day moving average on September 17, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for TSLL crossed bullishly above the 50-day moving average on September 11, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.

Following a +13.82% 3-day Advance, the price is estimated to grow further. Considering data from situations where TSLL advanced for three days, in 248 of 261 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.

The Aroon Indicator entered an Uptrend today. In 172 of 183 cases where TSLL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 90%.

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for TSLL turned negative on September 28, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 36 similar instances when the indicator turned negative. In 32 of the 36 cases the stock turned lower in the days that followed. This puts the odds of success at 89%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TSLL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

TSLL broke above its upper Bollinger Band on September 03, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Notable companies

The most notable companies in this group are Tesla (NASDAQ:TSLA).

Industry description

The investment seeks daily investment results, before fees and expenses, of 200% of the daily performance of TSLA. The fund, under normal circumstances, invests at least 80% of its net assets (plus any borrowings for investment purposes) in the securities of TSLA and financial instruments, such as swap agreements and options, that provide leveraged exposure to TSLA. The fund is non-diversified.

High and low price notable news

The average weekly price growth across all stocks in the Direxion Daily TSLA Bull 2X ETF (TSLL) ETF was 12%. For the same ETF, the average monthly price growth was 12%, and the average quarterly price growth was 1%. TSLA experienced the highest price growth at 6%, while TSLA experienced the biggest fall at 6%.
View a ticker or compare two or three
TSLL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Category Trading

Category
Trading--Leveraged Equity
Address
Direxion Shares ETF Trust33 Whitehall Street,10th FloorNew York
Phone
866-476-7523
Web
http://www.direxioninvestments.com/
Interact to see
Advertisement
I've been following ANTX, a biopharmaceutical company based in Menlo Park, California, that develops novel small molecule therapeutics from its proprietary boron chemistry platform. The focus is on underserved areas like infectious diseases, with the lead candidate epetraborole advancing in Phase 3 trials for non-tuberculous mycobacterial (NTM) lung disease and acute melioidosis. The pipeline also includes AN2-502998 for chronic Chagas disease in preclinical stages, along with programs in oncology.
Tilly's, Inc. (TLYS) operates as a specialty retailer specializing in casual apparel, footwear, accessories, and hardgoods aimed at young men, women, boys, and girls. The company focuses on branded fashion inspired by action sports, surf, and skate culture, offering products like tops, bottoms, swimwear, backpacks, hats, and sunglasses from well-known brands such as Vans and Hurley. With approximately 223 stores in malls and lifestyle centers, complemented by e-commerce through www.tillys.com, Tilly's effectively combines physical and digital sales channels.
Aemetis, Inc. (AMTX) is a renewable natural gas and renewable fuels company focused on developing and commercializing low- and negative-carbon intensity products that replace petroleum-based fuels. The company operates through segments including California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. Its core business model centers on converting agricultural waste—such as dairy manure into biogas and corn/wood waste into ethanol—into high-value biofuels like renewable natural gas (RNG), ethanol, biodiesel, and sustainable aviation fuel precursors.
Silvaco Group, Inc. (SVCO) provides technology computer-aided design (TCAD) software, electronic design automation (EDA) software, and semiconductor intellectual property (SIP) solutions. The company helps semiconductor and photonics firms design, simulate, and optimize processes from atomic-level modeling to complex system-on-chip (SoC) development. Its business centers on licensing software tools and IP blocks, along with engineering services, targeting high-growth areas like AI, power devices, automotive, foundries, and 5G/6G mobile.
UBXG stock surged +79% over the last 30 days, driven by heightened trading volume and positive market sentiment amid broader technology sector trends. Over the past quarter, the stock rose +61%, reflecting recovery from earlier lows near its 52-week bottom.
CVGI stock surged approximately +89% over the last 30 days, driven by strong Q4 2025 earnings beat on revenue and positive 2026 guidance. Over the past quarter, shares rose about +126%, reflecting improved profitability, debt reduction, and a key partnership announcement.
SAFX stock surged +104% over the past 30 days, driven by positive updates on a $10 million capital raise and merger progress. Over the past quarter, the stock rose +44%, reflecting recovery from lows amid renewable energy sector interest and strategic developments.
LONA stock surged +80% over the past 30 days, driven by positive analyst upgrades, executive appointments, and full-year financial updates highlighting pipeline progress. Over the past quarter, shares rose +48%, reflecting improved investor sentiment in biotech amid clinical advancements.
Lifetime Brands (LCUT) stock surged +77% over the last 30 days, driven by a strong Q4 earnings beat and a Zacks Rank #1 (Strong Buy) upgrade that reflects an improved earnings outlook. Over the past quarter, shares rose +48%, supported by profitability gains despite softer sales, with adjusted EBITDA reaching $50.8 million for full-year 2025.
CURV stock surged approximately +73% over the last 30 days, driven primarily by a positive reaction to Q4 and fiscal 2025 earnings that beat expectations on EPS and revenue. Over the past quarter, the stock is up around +55%, reflecting recovery from lows near $1 amid ongoing store optimization and sub-brand launches
Blaize Holdings, Inc. (BZAI) focuses on artificial intelligence (AI)-enabled edge computing solutions, offering programmable AI processors and platforms for verticals such as smart cities, defense, retail, and enterprise markets. The company's core revolves around hardware like the Graph Streaming Processor (GSP) AI accelerator, compute cards, and software tools including Blaize AI Studio—a no-code/low-code environment for deploying AI models without source code expertise. Based in El Dorado Hills, California, and founded in 2010, it went public through a merger in early 2025.
Comstock Holding Companies, Inc. (CHCI) operates as an asset manager, developer, and operator of mixed-use and transit-oriented properties, mainly in the greater Washington, D.C. metropolitan area. The company targets high-growth urban and suburban markets, overseeing a portfolio that spans residential, commercial, hospitality, and parking assets near key metro stations. Its asset-light, fee-based model delivers recurring revenue through property management, leasing, development services, and asset recapitalization for institutional investors, family offices, and governments.
ORIC Pharmaceuticals shares are down approximately 21% in premarket trading on April 1, 2026, from a prior session close of approximately $12.19, placing the premarket price near $9.63. The primary catalyst is the after-market release of Phase 1b dose optimization data for rinzimetostat (ORIC-944) on March 31, alongside the selection of 400 mg once daily as the recommended Phase 3 dose for the Himalayas-1 registrational trial.
Shares of Target Hospitality Corp. (Nasdaq: TH) surged approximately 38% during Wednesday's trading session, climbing from a prior close of $9.28 to approximately $12.81. The primary catalyst is the company's announcement of a landmark multi-year lease and services agreement worth over $550 million with a top-five global hyperscaler to build and operate a data center workforce community in North Texas.
Shares of Turning Point Brands (TPB) are falling sharply intraday on April 1, 2026, shedding approximately 15% from their prior session close of roughly $87.41, placing the stock near $74.30. The primary catalyst is broad investor risk-off selling tied to mounting trade-policy uncertainty ahead of President Trump's sweeping tariff announcements scheduled for April 2 — a day the administration has branded "Liberation Day".
Shares of Philip Morris International fell approximately 8% during intraday trading on April 1, 2026, dropping from a prior close of $165.34 to around $152.11. A sharp, broad-based market selloff — amplified by renewed trade policy tensions — is acting as the primary macro catalyst behind the decline.
WDC shares surged approximately +10% in Wednesday's session, advancing to approximately $296–$297 from a prior close near $269.82 on March 31, 2026. The primary catalyst is a major analyst upgrade: Bernstein raised its rating on Western Digital from Market Perform to Outperform and dramatically doubled its price target to $340 from $170.
I've been following CG Oncology, Inc. (CGON), a late-stage clinical biopharmaceutical company dedicated to developing and commercializing cretostimogene grenadenorepvec. This investigational oncolytic immunotherapy aims to serve as a bladder-sparing therapeutic for patients with non-muscle invasive bladder cancer (NMIBC). The company's focus remains on pushing this intravesical therapy through Phase 3 trials to address high unmet needs in BCG-unresponsive and intermediate-risk NMIBC, where treatments like BCG frequently fall short. In the broader biotech landscape, CG Oncology stands out with cretostimogene's encouraging durability and tolerability, which could position it as a foundational therapy. From what I see, these solid fundamentals—bolstered by strong clinical data and regulatory steps—have directly supported the recent stock price gains amid positive trial developments.
From what I see, Home Depot (HD) remains the world's largest home improvement retailer, operating over 2,300 stores across North America with a broad selection of products for construction, renovation, and maintenance. The company blends big-box retail with an expanding e-commerce platform and tailored services for professional contractors, drawing revenue from both do-it-yourself (DIY) consumers and do-it-for-me (DIFM) pros. In a competitive landscape against players like Lowe's, HD maintains dominance through its scale, efficient supply chain, and strong loyalty programs. Much of its performance ties directly to the housing market—home sales, remodeling, and repairs—which explains the recent pressure on the stock from subdued activity and high mortgage rates limiting turnover and major projects.
GE Aerospace (GE) stock declined -12% over the past 30 days, falling from around $333 to $293, amid profit-taking after record highs near $348. Over the past quarter, the stock is down -8%, reflecting post-earnings selloff despite strong Q4 2025 results with 20% revenue growth.